On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated formulary chapters, pathways or other GMMMG guidance. You can comment on current proposals via the links in the table below.

Please direct any questions to the secretariat at nuth.enquiries.gmmmg@nhs.net.

Title Information Feedback End Date
GMMMG Clinical Reference Group proposed actions from May 2022 On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the May 2022 CRG meeting. This consultation period is open until 5pm on Thursday 30th June 2022 Feedback Form June 30th, 2022
GMMMG Clinical Reference Group proposed actions from June 2022 On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the June 2022 CRG meeting. This consultation period is open until 5pm on Thursday 28th July 2022 Feedback Form July 28th, 2022
GMMMG DOAC Statement On behalf of the GMMMG Clinical Reference Group, we now seek comments on a statement on choice of DOAC for treatment of non-valvular atrial fibrillation. This consultation period is open until 5pm on Monday 1st August 2022 Feedback Form August 1st, 2022
GMMMG Hypersalivation Pathway On behalf of the GMMMG Clinical Reference Group, we now seek comments on a draft pathway for management of hypersalivation. This consultation period is open until 5pm on Monday 1st August 2022 Feedback Form August 1st, 2022